New directions in Ni-catalyzed cross coupling
镍催化交叉偶联的新方向
基本信息
- 批准号:9897556
- 负责人:
- 金额:$ 39.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcetalsAddressAlkenesAminesAreaAziridinesBiologicalBiologyCarbonCatalysisComplementComplexCouplingDataDevelopmentElectronsEthersFoundationsFree RadicalsGoalsHydrogen BondingIonsLaboratoriesLigandsMethodsMolecular StructureNatural ProductsOrganic SynthesisPharmaceutical ChemistryPhosphinesPhotochemistryPhysical condensationPlayPreparationReactionResearchRoleTransition ElementsWorkbiological preparationcatalystchemical reactiondesignhuman diseasemolecular manufacturingnovelpredictive modelingprogramsscaffoldsmall moleculesuccesstool
项目摘要
7. Project Summary/Abstract
The overarching goal of this program is to facilitate the discovery and preparation of complex, biologically
active small molecules by devising novel chemical reactions and elucidating new principles of catalysis in the
field of transition metal-catalyzed cross coupling. Our laboratory's early work demonstrated that oxidative
addition of Ni to iminium or oxocarbenium ion intermediates offers a novel entry to C(sp3)–C cross coupling.
This strategy leverages the modularity of cross-coupling catalysis to deliver new bond-forming reactions with
classic reactive intermediates in organic synthesis. Recently, we and others recognized that Ni catalysis
presents a powerful opportunity to functionalize another class of reactive intermediate in organic synthesis:
carbon-centered radicals. In the current proposal, we advance this concept, building on strong preliminary
data, to develop fundamentally new bond-forming reactions under exceptionally mild conditions. An example
is the development of a unified platform for the enantioselective synthesis of α- and β-substituted amines and
ethers, some of the most ubiquitous scaffolds in medicinal chemistry, via Ni-catalyzed coupling with radicals
derived from acetals, aziridines, and iminium ions accessed via condensation of an amine and carbonyl
derivative. Such transformations are uniquely suited to late-stage diversification under mild conditions and
address many challenges and limitations of ether and amine synthesis by C–O/N bond formation. Our group
has also established a new paradigm for catalytic C(sp3)–H functionalization that uses photocatalysis to deliver
free radical species from C(sp3)–H bonds, and Ni catalysis to functionalize these radicals. This strategy offers
numerous opportunities for late-stage C(sp3)–C bond formation that complement current approaches to C–H
functionalization in selectivity and scope. We describe plans to advance these reaction platforms in terms of
scope of coupling partners, catalyst control of regio- and stereoselectivity, and amenability to late-stage
derivatization of natural products and medicinal compounds. Critical to our success will be the development
and study of three ligand classes for Ni: phosphines featuring remote steric hindrance, bioxazolines, and
electron-deficient olefins. Since most effort in the field of Ni catalysis has focused on reaction discovery, we
expect that the development of ligands designed specifically for Ni will play a crucial role in advancing the
capabilities of this field. Similarly, we will build on our lab's prior mechanistic work with the goal of developing
predictive models for the reactivity of Ni with radicals and understanding the photochemistry and
photophysics of Ni that could lay the foundation for advances in numerous fields.
7.项目总结/摘要
该计划的总体目标是促进发现和制备复杂的,生物
通过设计新颖的化学反应和阐明催化的新原理,
过渡金属催化的交叉耦合领域。我们实验室的早期工作表明,
Ni与亚胺鎓或氧代碳鎓离子中间体的加成提供了C(sp3)-C交叉偶联的新途径。
该策略利用交叉偶联催化的模块性来提供新的成键反应,
有机合成中典型的活性中间体。最近,我们和其他人认识到,镍催化
为有机合成中另一类反应性中间体的官能化提供了强大的机会:
以碳为中心的自由基在目前的提案中,我们提出了这一概念,建立在强大的初步
数据,在非常温和的条件下开发全新的成键反应。例
是开发用于α-和β-取代胺的对映选择性合成的统一平台,
醚,一些在药物化学中最普遍的支架,通过镍催化与自由基偶联
由缩醛、氮丙啶和亚胺鎓离子通过胺和羰基缩合得到
衍生物这种转变特别适合于温和条件下的后期多样化,
通过C-O/N键形成解决醚和胺合成的许多挑战和限制。我们集团
还建立了催化C(sp3)-H功能化的新范式,
来自C(sp3)-H键的自由基物质,以及使这些自由基官能化的Ni催化剂。该战略提供
后期C(sp3)-C键形成的许多机会,补充了目前的C-H方法
功能化的选择性和范围。我们从以下方面描述了推进这些反应平台的计划
偶联配偶体的范围、催化剂对区域和立体选择性的控制以及对后期反应的适应性
天然产物和药用化合物的衍生化。我们成功的关键在于
研究了镍的三种配体:具有远位阻的膦,双恶唑啉,
缺电子烯烃。由于镍催化领域的大部分努力都集中在反应发现上,我们
我预计,专门为Ni设计的配体的开发将在推进镍的研究中发挥至关重要的作用。
这个领域的能力。同样,我们将建立在我们实验室先前的机械工作的基础上,
镍与自由基反应性的预测模型,并了解光化学和
镍的电子物理学可以为许多领域的进步奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abigail Gutmann Doyle其他文献
Abigail Gutmann Doyle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Abigail Gutmann Doyle', 18)}}的其他基金
New Directions in Nickel and Photoredox Catalysis
镍和光氧化还原催化的新方向
- 批准号:
10623946 - 财政年份:2018
- 资助金额:
$ 39.07万 - 项目类别:
Metal-Catalyzed Cross Coupling with N,O-Acetals and Acetals
N,O-缩醛和缩醛的金属催化交叉偶联
- 批准号:
9035402 - 财政年份:2013
- 资助金额:
$ 39.07万 - 项目类别:
Metal-Catalyzed Cross Coupling with N,O-Acetals and Acetals
N,O-缩醛和缩醛的金属催化交叉偶联
- 批准号:
8580437 - 财政年份:2013
- 资助金额:
$ 39.07万 - 项目类别:
Metal-Catalyzed Cross Coupling with N,O-Acetals and Acetals
N,O-缩醛和缩醛的金属催化交叉偶联
- 批准号:
8690110 - 财政年份:2013
- 资助金额:
$ 39.07万 - 项目类别:
Metal-Catalyzed Cross Coupling with N,O-Acetals and Acetals
N,O-缩醛和缩醛的金属催化交叉偶联
- 批准号:
8822307 - 财政年份:2013
- 资助金额:
$ 39.07万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.07万 - 项目类别:
Research Grant